Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2415-2420

  Squizzato, Alessandro ^a,b,c   Romualdi, E ^a   Buller H R ^b   Gerdes, V E A ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING TENDENCY; BLEEDING TIME; BLOOD CLOTTING; CASE CONTROL STUDY; COHORT ANALYSIS; EMBASE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTHYROIDISM; HYPOTHYROIDISM; INTERVENTION STUDY; MEDICAL INFORMATION; MEDLINE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; THYROID DISEASE;

EID: 34447124476     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0199     Document Type: Review

References (63)

1. Squizzato A, Gerdes VEA, Brandjes DPM, Buller HR, Stam J 2005 Thyroid diseases and cerebrovascular disease. Stroke 36:2302-2310
2. Hofbauer LC, Heufelder AE 1997 Coagulation disorders in thyroid diseases. Eur J Endocrinol 136:1-7
3. Marongiu F, Cauli C, Mariotti S 2004 Thyroid, hemostasis and thrombosis. J Endocrinol Invest 27:1065-1071
4. Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH 2004 Thyroid hormone receptor dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology 145:2804-2814
5. Roberts CGP, Ladenson PW 2004 Hypothyroidism. Lancet 363:793-803
6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
7. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P 2006 Newcastle-Ottawa Scale. http://www.lri.ca/programs/ceu/oxford htm
8. 2006 Cochrane handbook for systematic reviews of intervention. In: The Cochrane Library, Issue 2. Oxford, UK: Update Software
9. Rogers II JS, Stanley RS 1983 Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 102:444-449
10. Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S 2002 Apathetic Graves' disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 25:246-249
11. Lloyd JV, Tunbridge LJ 1981 Coagulation inhibitor in hypothyrodism. Br Med J (Clin Res Ed) 283:500
12. Bruckert E, Giral P, Chadarevian R, Turpin G 1999 Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients. J Cardiovasc Risk 6:327-331
13. Razvi S, Weaver JU, Canturk Z 2004 Subclinical hypothyroidism and cardiovascular risk (multiple letters). Thyroid 14:870-872
14. Watzke H, Schwarz HP, Weissel M 1987 Fibronectin during thyroid hormone replacement therapy. Thromb Res 46:347-353
15. Cucuianu M, Nussbaum A, Cristea A, Vladutiu T, Roman S, Stoica D 1987 High levels of plasma von Willebrand factor in hyperthyroidism. Rev Roum Med 25:205-210
16. Horne III MK, Singh KK, Rosenfeld KG, Wesley R, Skarulis MC, Merryman PK, Cullinane A, Costello R, Patterson A, Eggerman T, Bernstein DM, Pucino F, Csako G 2004 Is thyroid hormone suppression therapy prothrombotic? J Clin Endocrinol Metab 89:4469-4473
17. Chadarevian R, Bruckert E, Giral P, Turpin G 1999 Relationship between thyroid hormones and fibrinogen levels. Blood Coag Fibrinol 10:481-486
18. Gallist S, Sudi KM, Leschnik B, Muntean W, Borkenstein MH 2000 Inverse correlation between thyroid function and haemostatic markers for coronary heart disease in obese children and adolescents. J Pediatr Endocrinol Metab 13:1615-1620
19. Franchini M, De Gironcoli M, Lippi G, Manzato F, Brazzarola P, Bottura D, Aprili G, Gandini G 2002 Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing throid surgery. Haemophilia 8:142-144
20. Franchini M, Zugni C, Veneri D, Gandini G, Lippi G, Manzato F, Brazzarola P 2004 High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 89:1341-1346
21. Franchini M, Veneri D, Lippi G 2005 Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 93:392-393
22. Arnaout MA, Awidi AS, El-Najdawi AM, Khateeb MS, Ajlouni KM 1992 Arginine-vasopressin and endothelium-associated proteins in thyroid disease. Acta Endocrinol 126:399-403
23. Burggraaf J, Lalezari S, Emei JJ, Vischer UM, De Meyer PHEM, Pijl H, Cohen AF 2001 Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 11:153-160
24. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M, Duman C 2003 Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 13:971-977
25. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G 1998 Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 79:99-103
26. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G 2001 Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86:732-737
27. Chadarevian R, Jublanc C, Bruckert E, Giral P, Ankri A, Leenhardt L, Chapman J, Turpin G 2005 Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. J Endocrinol Invest 28:398-404
28. Coban E, Aydemir M, Yazicioglu G, Ozdogan M 2006 Endothelial dysfunction in subjects with subclinical hyperthyroidism. J Endocrinol Invest 29:197-200
29. Dorr M, Robinson DM, Wallaschofski H, Schwahn C, John U, Felix SB, Volzke H 2006 Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocrinol Metab 91:530-534
30. Erem C 2006 Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 64:323-329
31. Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, Telatar M 2002 Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 25:345-350
32. Erem C, Kavgaci H, Ersoz H, Hacihasanoglu A, Ukinc K, Karti SS, Deger O, Telatari M 2003 Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 57:78-81
33. Erfurth EM, Ericsson UB, Egervall K, Lethagen SR 1995 April Effect of acute desmopressin and of long-term thyroxine replacement on haemostasis in hypothyroidism. Clin Endocrinol (Oxf) 42:373-378
34. Graninger W, Pirich KR, Speiser W 1986 Effect of thyroid hormones on plasma protein concentrations in man. J Clin Endocrinol Metab 63:407-411
35. Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M 2005 Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J 52:363-367
36. Gullu S, Sav H, Kamel N 2005 Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 152:355-361
37. Gursoy A, Ozduman Cin M, Kamel N, Gullu S 2006 Which thyroid-stimulating hormone level should be sought in hypothyroid patients under lthyroxine replacement therapy. Int J Clin Pract 60:655-659
38. Jorde R, Figenschau Y, Hansen JB 2006 Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromso study. Thromb Haemost 95: 750-751
39. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J 2004 Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 61:232-238
40. Levesque H, Borg JY, Cailleux N, Vasse M, Daliphard S, Gancel A, Monconduit M, Courtois H 1993 Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Eur J Med 2:287-288
41. Li Y, Chen H, Tan J, Wang X, Liang H, Sun X 1998 Impaired release of tissue plasminogen activator from the endothelium in Graves' disease: indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest 28:1050-1054
42. Liu L, Wang X, Lin Z, Wu H 1993 Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through β-adrenergic receptors. Endocr Res 19:123-133
43. Marongiu F, Conti M, Mameli G, Murtas ML, Balzano S, Sorano G, Mamusa AM, Martino E 1988 Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 11:723-725
44. Marongiu F, Conti M, Murtas ML, Sorano GG, Mameli G, Salis G, Mathieu A, Martino E 1991 Anticardiolipin antibodies in Grave's disease: relationship with thrombin activity in vivo. Thromb Res 64:745-749
45. Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E 1991 Activation of blood coagulation and fibrinolysis in Graves' disease. Horm Metab Res 23:609-611
46. Marongiu F, Biondi G, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E 1992 Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 67:729
47. Morishita E, Hashimoto T, Asakura H, Saito M, Yamazaki M, Aoshima K, Yoshida T, Kato H, Matsuda T 1998 Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease. Thromb Haemost 79:919-923
48. Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA 2001 Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 31:131-137
49. Myrup B, Bregengard C, Faber J 1995 Primary haemostasis in thyroid disease. J Intern Med 238:59-63
50. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y 2004 Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid fuction after levothyroxine replacement therapy. Eur J Endocrinol 150:125-131
51. Nagasaki T, Inaba M, Kumeda Y, Ueda M, Hiura Y, Tahara H, Ishimura E, Onoda N, Ishikawa T, Nishizawa Y 2005 Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function. Biomed Pharmacother 59:8-14
52. Ozcan MA, Comlekci A, Demirkan F, Yuksel F, Sari I, Demir T, Ozsan GH, Oruk G, Yesil S, Undar B 2003 Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 110:243-247
53. Palareti G, Biagi G, Legnani C, Bianchi D, Serra D, Savini R, Coccheri S 1989 Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 62:1053-1056
54. Rogers II JS, Shane SR, Jencks FS 1982 Factor VIII activity and thyroid function. Ann Intern Med 97:713-716
55. Rosc D, Zastawna E, Drewniak W, Michalski A, Kotschy M 1998 Plasminogen activators (tissue type t-PA, urokinase type u-PA) and plasminogen activator inhibitor type 1 (PAI-1) in Graves disease. Med Sci Monit 4:975-978
56. Wahrenberg H, Wennlund A, Hoffstedt J 2002 Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor α, in Graves' hyperthyroidism. Eur J Endocrinol 146: 607-611
57. Yong PH, Junit SM, Harun F, Hashim OH 2006 Patients with congenital hypothyroidism demonstrate different altered expression of plasma fibrinogen and haptoglobin polypeptide chains. Clin Biochem 39:126-132
58. Stassen JM, Arnout J, Deckmyn H 2004 The hemostatic system. Curr Med Chem 11:2245-2260
59. Squizzato A, Gerdes VEA, Ageno W, Buller HR 2006 The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med, in press
60. Juni P, Witschi A, Bloch R, Egger M 1999 The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054-1060
61. Jawadi MH, Ho L, Dejong DC 1984 Effect of TRH on plasma arginin vasopressin. Horm Res 19:91-96
62. Lowe GDO 2006 Arterial disease and venous thrombosis: are they related, and if so, what should we do about? J Thromb Haemost 4:1882-1885
63. Agnelli G, Becattini C 2006 Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost 4:1886-1890